6-KThe Wire
Innate Pharma SA files 6-K
Filed Apr 13, 2026 · 2mo ago · Accession 0001628280-26-024822
Plain English
Innate Pharma announced on April 13, 2026, that it has entered into a definitive agreement to sell its Lumoxiti rights to AstraZeneca. This transaction is expected to provide Innate Pharma with a significant upfront payment and potential future milestone payments.
Filing details
- Company
- Innate Pharma SA
- Ticker
- IPHA
- CIK
- 1598599
- Form type
- 6-K
- Filing date
- Apr 13, 2026
- Report date
- Apr 13, 2026
- Document
- a6k-iphx2604132.htm
- Size
- 24 KB